Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women.

After two control cycles, 13 normally menstruating women were treated from day 5 to 25 of the third consecutive cycle with nomegestrol acetate (NOM Ac) 1.25, 2.5 or 5 mg once a day.